Study finds old-school formulas still beat market, but not invincible. Valuation matters - right cheap stocks reduce risk while delivering returns.

Valmet Oyj's fourth-quarter 2024 earnings fell short of analyst expectations, with an earnings per share (EPS) of $0.60 compared to the forecasted $0.6971. Revenue also missed expectations, totaling ...

Gentian Diagnostics reported a robust financial performance for Q4 2024, achieving record quarterly sales of NOK 42.6 million, marking a 14% year-over-year increase. The company's stock surged by 7.58 ...